Retail Pharmacy Forecast 2022
Chain Drug Review, George Rafferty and Jennifer Zilka
Top industry executives discuss the prospects for their businesses and the sector as a whole for 2022. With the pandemic surging, pharmacy chains are planning for new solutions to fight the variants. At the same time retailers are looking to broaden affordable and accessible health care offerings when many people find such services from more traditional providers out of financial reach. Chains are also bolstering their e-commerce appeal to entice omnichannel shoppers. Top industry executives discuss the prospects for their businesses and the sector as a whole for 2022.
For the full article, please visit Chain Drug Review.
Cencora.com is providing automated translations to assist in reading the website in languages other than English. For these translations, reasonable efforts have been made to provide an accurate translation, however, no automated translation is perfect nor is it intended to replace human translators. These translations are provided as a service to users of Cencora.com and are provided "as is." No warranty of any kind, either expressed or implied, is made as to the accuracy, reliability, or correctness of any of these translations made from English into any other language. Some content (such as images, videos, Flash, etc.) may not be accurately translated due to the limitations of the translation software.
Any discrepancies or differences created in translating this content from English into another language are not binding and have no legal effect for compliance, enforcement, or any other purpose. If any errors are identified, please contact us. If any questions arise related to the accuracy of the information contained in these translations, please refer to the English version of the page.